NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets tricky lung cancer transformation after TKI failure
Disease control Not yet recruitingThis study tests a combination of limertinib plus chemotherapy (carboplatin and etoposide) in 30 adults with a specific type of lung cancer (EGFR-mutant NSCLC) that has transformed into small cell lung cancer after initial targeted therapy stopped working. The goal is to see if t…
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New drug combo aims to shrink advanced cancers in early trial
Disease control Not yet recruitingThis study tests a new drug called QLS5132 combined with other cancer treatments for people with advanced solid tumors, including stomach, lung, endometrial, and ovarian cancers. The goal is to find safe doses and see if the combination can shrink tumors. About 626 participants w…
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:14 UTC
-
Taiwan study checks if Pre-Surgery drug combo helps lung cancer patients
Knowledge-focused Not yet recruitingThis study will look back at medical records of 100 adults in Taiwan with non-small cell lung cancer who received nivolumab plus chemotherapy before surgery. The goal is to see how well this treatment works and if it is safe. Researchers will check if the cancer disappears comple…
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC